Fumiko Sekiguchi

Title: Fumiko Sekiguchi: Innovator in Calcium Channel Inhibitors

Introduction

Fumiko Sekiguchi is a prominent inventor based in Higashiosaka, Japan. She has made significant contributions to the field of pharmacology, particularly in the development of T-type calcium channel inhibitors. With a total of two patents to her name, her work focuses on innovative therapeutic solutions.

Latest Patents

Fumiko Sekiguchi's latest patents revolve around T-type calcium channel inhibitors, which are designed as new analgesics targeting T-type calcium channels. The first patent presents a compound represented by a specific formula, which serves as a T-type calcium channel inhibitor. This invention also includes a medicament containing the inhibitor and a therapeutic or prophylactic agent for diseases that benefit from T-type calcium channel inhibition. The second patent similarly outlines a T-type calcium channel inhibitor, including its pharmaceutically acceptable salts and solvates. This patent also details a pharmaceutical product containing the inhibitor and a therapeutic agent for diseases affected by T-type calcium channel activity.

Career Highlights

Fumiko Sekiguchi has worked with notable institutions, including Kinki University and Fuso Pharmaceutical Industries, Ltd. Her experience in these organizations has contributed to her expertise in the development of innovative pharmaceutical solutions.

Collaborations

Fumiko has collaborated with esteemed colleagues such as Atsufumi Kawabata and Hiroyuki Nishikawa. These partnerships have likely enhanced her research and development efforts in the field of pharmacology.

Conclusion

Fumiko Sekiguchi stands out as a dedicated inventor in the realm of calcium channel inhibitors, with her innovative patents paving the way for new therapeutic options. Her contributions to pharmacology reflect her commitment to advancing medical science.